APA (7th ed.) Citation

Gojaseni, P., Wattanakul, J., Chuasuwan, A., & Chittinandana, A. SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Gojaseni, Pongsathorn, Jananya Wattanakul, Anan Chuasuwan, and Anutra Chittinandana. SGLT2 Inhibitor Dapagliflozin Reduces Proximal Tubular Cell Damage Biomarkers in Patients with Acute Heart Failure. Taylor & Francis Group.

MLA (9th ed.) Citation

Gojaseni, Pongsathorn, et al. SGLT2 Inhibitor Dapagliflozin Reduces Proximal Tubular Cell Damage Biomarkers in Patients with Acute Heart Failure. Taylor & Francis Group.